To investigate thresholds for lymph node yield (LNY), lymph node density (LND), and pN in patients with oral squamous cell carcinoma in relation to previous findings in the literature.
Appropriate thresholds for LNY, LND, and pN were determined by areas under the curve and subsequently subjected to multivariate analysis. Five-year overall survival and 3-year recurrence-free survival were determined by Kaplan-Meier survival curves.
Results
In total, 413 patients diagnosed with oral squamous cell carcinoma were included. In the pN0 cohort, no superior/prognostic LNY cutoff values were detected. In the pN+ cohort, areas under the curve determined thresholds of LNY, LND, and pN to be 21 nodes, 5%, and 3 metastases, respectively. The 5-year overall survival was 52% for patients with LNY ≥21 vs 38% for patients with LNY <21 (hazard ratio [HR], 1.49; 95% CI, 1.05-2.11; P < .05), 60% for patients with LND ≤5% vs 38% for patients with LND >6% (HR, 1.63; 95% CI, 1.03-2.57; P < .05), and 43% for patients with pN <3 vs 26% for patients with pN ≥3 (HR, 1.40; 95% CI, 1.04-2.15; P < .05).
Conclusions
Increased nodal yield, decreased LND, and decreasing number of pN were associated with significantly improved survival outcomes. LNY might serve as a prognosticator of survival as well as a surgical quality indicator. LND may have implications as a tool in cancer staging and treatment planning.
CianchiFPalombaABoddiV, et al. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg. 2002;26(3):384-389. doi:10.1007/s00268-001-0236-8
2.
BandoEYonemuraYTaniguchiKFushidaSFujimuraTMiwaK. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol. 2002;9(8):775-784. doi:10.1007/BF02574500
3.
BergerACSigurdsonERLeVoyerT, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23(34):8706-8712. doi:10.1200/JCO.2005.02.8852
4.
ChanJKKappDSCheungMK, et al. The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients. Br J Cancer. 2007;97(5):605-611. doi:10.1038/sj.bjc.6603898
5.
SierzegaMPopielaTKuligJNowakK. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas. 2006;33(3):240-245. doi:10.1097/01.mpa.0000235306.96486.2a
6.
ChenSLBilchikAJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg. 2006;244(4):602-610. doi:10.1097/01.sla.0000237655.11717.50
7.
EbrahimiAZhangWJGaoKClarkJR. Nodal yield and survival in oral squamous cancer: defining the standard of care. Cancer. 2011;117(13):2917-2925. doi:10.1002/cncr.25834
8.
DiviVChenMMNussenbaumB, et al. Lymph node count from neck dissection predicts mortality in head and neck cancer. J Clin Oncol. 2016;34(32):3892-3897. doi:10.1200/JCO.2016.67.3863
9.
DiviVHarrisJHarariPM, et al. Establishing quality indicators for neck dissection: correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234). Cancer. 2016;122(22):3464-3471. doi:10.1002/cncr.30204
10.
EbrahimiAClarkJRAmitM, et al. Minimum nodal yield in oral squamous cell carcinoma: defining the standard of care in a multicenter international pooled validation study. Ann Surg Oncol. 2014;21(9):3049-3055. doi:10.1245/s10434-014-3702-x
BöttcherADommerichSSanderS, et al. Nodal yield of neck dissections and influence on outcome in laryngectomized patients. Eur Arch Otorhinolaryngol. 2016;273(10):3321-3329. doi:10.1007/s00405-016-3928-2
13.
SchoppyDWRhoadsKFMaY, et al. Measuring institutional quality in head and neck surgery using hospital-level data: negative margin rates and neck dissection yield. JAMA Otolaryngol Head Neck Surg. 2017;143(11):1111-1116. doi:10.1001/jamaoto.2017.1694
14.
LeónXVenegasMdelPCasasayasM, et al. Prognostic value of the nodal yield in elective neck dissections in patients with head and neck carcinomas. Eur Arch Otorhinolaryngol. 2022;279(2):883-889. doi:10.1007/s00405-021-06819-0
15.
EbrahimiAClarkJRZhangWJ, et al. Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma. Head Neck. 2011;33(9):1245-1251. doi:10.1002/hed.21600
16.
GilZCarlsonDLBoyleJO, et al. Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer. 2009;115(24):5700-5710. doi:10.1002/cncr.24631
17.
PatelSGAmitMYenTC, et al. Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research. Br J Cancer. 2013;109(8):2087-2095. doi:10.1038/bjc.2013.570
18.
CheraghlouSOtrembaMKuo YuPAgogoGOHerseyDJudsonBL. Prognostic value of lymph node yield and density in head and neck malignancies. Otolaryngology. 2018;158(6):1016-1023. doi:10.1177/0194599818756830
19.
MarchianoEPatelTDEloyJABaredesSParkRCW. Impact of nodal level distribution on survival in oral cavity squamous cell carcinoma: a population-based study. Otolaryngol Neck Surg. 2016;155(1):99-105. doi:10.1177/0194599816636356
20.
RobertsTJColevasADHaraWHolsingerFCOakley-GirvanIDiviV. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas. Cancer. 2016;122(9):1388-1397. doi:10.1002/cncr.29932
21.
MamelleGPampurikJLuboinskiBLancarRLusinchiABosqJ. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg. 1994;168(5):494-498. doi:10.1016/s0002-9610(05)80109-6
22.
SpoerlSGerkenMMamilosA, et al. Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study. Clin Oral Investig. 2021;25(4):1705-1713. doi:10.1007/s00784-020-03471-6
23.
ShingakiSTakadaMSasaiK, et al. Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg. 2003;185(3):278-284. doi:10.1016/s0002-9610(02)01378-8
24.
MirianCGerdsTAPedersenMM, et al. Metrics of pN-staging in oral squamous cell carcinoma: an analysis of 1,905 patients. Eur J Cancer. 2021;150:33-41. doi:10.1016/j.ejca.2021.03.019
25.
Schmidt JensenJJakobsenKKMirianC, et al. The Copenhagen Oral Cavity Squamous Cell Carcinoma database: protocol and report on establishing a comprehensive oral cavity cancer database. Clin Epidemiol. 2019;11:733-741. doi:10.2147/CLEP.S215399
26.
ThygesenLCDaasnesCThaulowIBrønnum-HansenH. Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J public Heal. 39(7, suppl):12-16. doi:10.1177/1403494811399956
EdgeSBComptonCC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471-1474. doi:10.1245/s10434-010-0985-4
29.
AgramaMTReiterDCunnaneMFTophamAKeaneWM. Nodal yield in neck dissection and the likelihood of metastases. Otolaryngol Neck Surg. 2003;128(2):185-190. doi:10.1067/mhn.2003.67
30.
MerzSTimmesfeldNStuckBAWiegandS. Impact of lymph node yield on outcome of patients with head and neck cancer and pN0 neck. Anticancer Res. 2018;38(9):5347-5350. doi:10.21873/anticanres.12862
31.
RyuISRohJ-LChoK-JChoiS-HNamSYKimSY. Lymph node density as an independent predictor of cancer-specific mortality in patients with lymph node-positive laryngeal squamous cell carcinoma after laryngectomy. Head Neck. 2015;37(9):1319-1325. doi:10.1002/hed.23750
32.
KuoPMehraSSosaJA, et al. Proposing prognostic thresholds for lymph node yield in clinically lymph node–negative and lymph node–positive cancers of the oral cavity. Cancer. 2016;122(23):3624-3631. doi:10.1002/cncr.30227
33.
LemieuxAKedarisettySRajuSOroscoRCoffeyC. Lymph node yield as a predictor of survival in pathologically node negative oral cavity carcinoma. Otolaryngology. 2016;154(3):465-472. doi:10.1177/0194599815622409
34.
LinCYLeeLYChengNM, et al. cN+pN0 disease does not portend a less favorable prognosis compared with cN0pN0 in patients with resected oral cavity squamous cell carcinoma. Cancer Med. 2021;10(20):6947. doi:10.1002/CAM4.4187
35.
LemmensVEvan LijnschotenIJanssen-HeijnenMLRuttenHJVerheijCDCoeberghJ-WW. Pathology practice patterns affect lymph node evaluation and outcome of colon cancer: a population-based study. Ann Oncol. 2006;17(12):1803-1809. doi:10.1093/annonc/mdl312
36.
HolcombAJPerrymanMGoodwinS, et al. Pathology protocol increases lymph node yield in neck dissection for oral cavity squamous cell carcinoma. Head Neck. 2020;42(10):2872-2879. doi:10.1002/hed.26343
37.
LyonsAThavarajSSwarnkarP, et al. Treating the N0 neck in early stage oral cancer: a pause for re-assessment?Br J Oral Maxillofac Surg. Published online July5, 2022. doi:10.1016/j.bjoms.2021.07.024
38.
LörinczBBLangwiederFMöckelmannNSehnerSKnechtR. The impact of surgical technique on neck dissection nodal yield: making a difference. Eur Arch Otorhinolaryngol. 2016;273(5):1261-1267. doi:10.1007/s00405-015-3601-1
39.
ChristensenAJuhlKKissK, et al. Near-infrared fluorescence imaging improves the nodal yield in neck dissection in oral cavity cancer: a randomized study. Eur J Surg Oncol. 2019;45(11):2151-2158. doi:10.1016/J.EJSO.2019.06.039
40.
de KortWWBMaasSLNVan EsRJJWillemsSM. Prognostic value of the nodal yield in head and neck squamous cell carcinoma: a systematic review. Head Neck. 2019;41(8):2801-2810. doi:10.1002/hed.25764
41.
LiaoC-THsuehCLeeL-Y, et al. Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy. Oral Oncol. 2012;48(4):329-336. doi:10.1016/j.oraloncology.2011.10.017
42.
PrabhuRSHanasogeSMaglioccaKR, et al. Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. Head Neck. 2015;37(6):777-782. doi:10.1002/hed.23662
43.
ShrimeMGBacharGLeaJ, et al. Nodal ratio as an independent predictor of survival in squamous cell carcinoma of the oral cavity. Head Neck. 2009;31(11):1482-1488. doi:10.1002/hed.21114
44.
BrierleyJDGospodarowiczMKWittekindC. TNM Classification of Malignant Tumours. 8th ed.Union for International Cancer Control; 2016.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
